Literature DB >> 7424981

A simplified intrapartum numerical scoring system. The prediction of high risk in labor.

I Morrison, L Carter, S McNamara, M Cheang.   

Abstract

An analysis of 1,994 consecutive parturient women showed that 472 (23%) could be assigned to a high-risk category on the basis of an intrapartum score of greater than or equal to 3. Perinatal mortality, neonatal morbidity, and the rate for operative intervention were all significantly greater for the high-risk group (p < 0.0001). Of the total population, 11% were designated to be at high risk by combining intrapartum and antepartum scores, and 71% of this group had an abnormal intrapartum outcome (p < 0.0001). For this study, 63% of the patients with an abnormal outcome for labor were admitted to the labor floor for 6 hours or longer, and this is an indirect measurement of the potential that exists for optional management. The limitations of intrapartum scoring systems are discussed, particularly with respect to their design, the prediction of preventable deaths, and the category of hospital for which they might prove most useful.

Entities:  

Mesh:

Year:  1980        PMID: 7424981     DOI: 10.1016/0002-9378(80)90031-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

Review 1.  Reducing stillbirths: screening and monitoring during pregnancy and labour.

Authors:  Rachel A Haws; Mohammad Yawar Yakoob; Tanya Soomro; Esme V Menezes; Gary L Darmstadt; Zulfiqar A Bhutta
Journal:  BMC Pregnancy Childbirth       Date:  2009-05-07       Impact factor: 3.007

2.  Antenatal screening: its use in assessing obstetric risk factors in Zimbabwe.

Authors:  V D Tsu
Journal:  J Epidemiol Community Health       Date:  1994-06       Impact factor: 3.710

3.  High-risk pregnancies and their association with severe maternal morbidity in Nepal: A prospective cohort study.

Authors:  Sushma Rajbanshi; Mohd Noor Norhayati; Nik Hussain Nik Hazlina
Journal:  PLoS One       Date:  2020-12-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.